• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷脂头部基团对超声触发免疫脂质体药物释放和细胞摄取的影响。

Effect of phospholipid head group on ultrasound-triggered drug release and cellular uptake of immunoliposomes.

机构信息

Department of Chemical and Biological Engineering, American University of Sharjah, Sharjah, United Arab Emirates.

Materials Science and Engineering Program, American University of Sharjah, Sharjah, United Arab Emirates.

出版信息

Sci Rep. 2023 Oct 3;13(1):16644. doi: 10.1038/s41598-023-43813-4.

DOI:10.1038/s41598-023-43813-4
PMID:37789072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10547810/
Abstract

Liposomes are the most successful nanoparticles used to date to load and deliver chemotherapeutic agents to cancer cells. They are nano-sized vesicles made up of phospholipids, and targeting moieties can be added to their surfaces for the active targeting of specific tumors. Furthermore, Ultrasound can be used to trigger the release of the loaded drugs by disturbing their phospholipid bilayer structure. In this study, we have prepared pegylated liposomes using four types of phospholipids with similar saturated hydrocarbon tails including a phospholipid with no head group attached to the phosphate head (DPPA) and three other phospholipids with different head groups attached to their phosphate heads (DPPC, DPPE and DPPG). The prepared liposomes were conjugated to the monoclonal antibody trastuzumab (TRA) to target the human epidermal growth factor receptor 2 (HER2) overexpressed on HER2-positive cancer cells (HER2+). We have compared the response of the different formulations of liposomes when triggered with low-frequency ultrasound (LFUS) and their cellular uptake by the cancer cells. The results showed that the different formulations had similar size, polydispersity, and stability. TRA-conjugated DPPC liposomes showed the highest sensitivity to LFUS. On the other hand, incubating the cancer cells with TRA-conjugated DPPA liposomes triggered with LFUS showed the highest uptake of the loaded calcein by the HER2+ cells.

摘要

脂质体是迄今为止最成功的用于将化疗药物装载和递送到癌细胞的纳米颗粒。它们是由磷脂组成的纳米大小的囊泡,可以在其表面添加靶向部分,以对特定肿瘤进行主动靶向。此外,超声可以通过扰乱其磷脂双层结构来触发载药的释放。在这项研究中,我们使用四种具有相似饱和烃尾部的磷脂制备了聚乙二醇化脂质体,包括一种没有头部基团连接到磷酸头部的磷脂(DPPA)和三种具有不同头部基团连接到磷酸头部的其他磷脂(DPPC、DPPE 和 DPPG)。制备的脂质体与曲妥珠单抗(TRA)连接,以靶向在 HER2 阳性癌细胞(HER2+)上过表达的人表皮生长因子受体 2(HER2)。我们比较了不同配方的脂质体在低频超声(LFUS)触发下的反应及其被癌细胞摄取的情况。结果表明,不同配方具有相似的大小、多分散性和稳定性。TRA 缀合的 DPPC 脂质体对 LFUS 最敏感。另一方面,用 LFUS 触发的 TRA 缀合的 DPPA 脂质体孵育癌细胞显示出对负载钙黄绿素的摄取最高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/6ec237d38d17/41598_2023_43813_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/0411eec606ea/41598_2023_43813_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/224f24c4db4e/41598_2023_43813_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/472416d058dc/41598_2023_43813_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/189a616bfbdb/41598_2023_43813_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/c464a6c3363f/41598_2023_43813_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/b05a0a020808/41598_2023_43813_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/6ec237d38d17/41598_2023_43813_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/0411eec606ea/41598_2023_43813_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/224f24c4db4e/41598_2023_43813_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/472416d058dc/41598_2023_43813_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/189a616bfbdb/41598_2023_43813_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/c464a6c3363f/41598_2023_43813_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/b05a0a020808/41598_2023_43813_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f88/10547810/6ec237d38d17/41598_2023_43813_Fig7_HTML.jpg

相似文献

1
Effect of phospholipid head group on ultrasound-triggered drug release and cellular uptake of immunoliposomes.磷脂头部基团对超声触发免疫脂质体药物释放和细胞摄取的影响。
Sci Rep. 2023 Oct 3;13(1):16644. doi: 10.1038/s41598-023-43813-4.
2
Ultrasound-triggered herceptin liposomes for breast cancer therapy.超声触发曲妥珠单抗脂质体用于乳腺癌治疗。
Sci Rep. 2021 Apr 6;11(1):7545. doi: 10.1038/s41598-021-86860-5.
3
Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy.超声控制的雌酮修饰脂质体用于雌激素阳性乳腺癌治疗。
Artif Cells Nanomed Biotechnol. 2018;46(sup2):462-472. doi: 10.1080/21691401.2018.1459634. Epub 2018 Apr 12.
4
Effect of lipid composition on incorporation of trastuzumab-PEG-lipid into nanoliposomes by post-insertion method: physicochemical and cellular characterization.脂质组成对通过后插入法将曲妥珠单抗-聚乙二醇-脂质掺入纳米脂质体的影响:物理化学和细胞表征
J Liposome Res. 2016;26(2):113-25. doi: 10.3109/08982104.2015.1048692. Epub 2015 May 29.
5
Effect of Pegylation and Targeting Moieties on the Ultrasound-Mediated Drug Release from Liposomes.聚乙二醇化和靶向部分对脂质体超声介导的药物释放的影响。
ACS Biomater Sci Eng. 2020 Jan 13;6(1):48-57. doi: 10.1021/acsbiomaterials.8b01301. Epub 2019 Jul 3.
6
Targeting Breast Cancer Using Hyaluronic Acid-Conjugated Liposomes Triggered with Ultrasound.利用超声触发的透明质酸偶联脂质体靶向治疗乳腺癌。
J Biomed Nanotechnol. 2021 Jan 1;17(1):90-99. doi: 10.1166/jbn.2021.3012.
7
Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy.用于紫杉醇和雷帕霉素共递送以治疗乳腺癌的抗HER2免疫脂质体
Eur J Pharm Biopharm. 2017 Jun;115:159-167. doi: 10.1016/j.ejpb.2017.02.020. Epub 2017 Feb 28.
8
Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy.超声控制的白蛋白结合脂质体用于乳腺癌治疗。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):705-714. doi: 10.1080/21691401.2019.1573175.
9
Rapamycin-loaded Immunoliposomes Functionalized with Trastuzumab: A Strategy to Enhance Cytotoxicity to HER2-positive Breast Cancer Cells.曲妥珠单抗功能化的负载雷帕霉素免疫脂质体:增强对HER2阳性乳腺癌细胞细胞毒性的策略。
Anticancer Agents Med Chem. 2017;17(1):48-56.
10
HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents.用于改善抗癌药物递送的HER2特异性亲和体缀合热敏脂质体(亲和体脂质体)。
J Liposome Res. 2008;18(4):293-307. doi: 10.1080/08982100802457377.

引用本文的文献

1
Phospholipid-Drug Conjugates in Cancer Therapy: Emerging Paradigms and Future Directions.癌症治疗中的磷脂-药物偶联物:新兴模式与未来方向
AAPS PharmSciTech. 2025 Jul 14;26(6):190. doi: 10.1208/s12249-025-03175-8.
2
Liposomal Formulations: A Recent Update.脂质体制剂:近期进展
Pharmaceutics. 2024 Dec 30;17(1):36. doi: 10.3390/pharmaceutics17010036.
3
Research Progress of Phospholipid Vesicles in Biological Field.磷脂囊泡在生物领域的研究进展

本文引用的文献

1
pH-Responsive Nanocarriers in Cancer Therapy.癌症治疗中的pH响应性纳米载体
Polymers (Basel). 2022 Feb 26;14(5):936. doi: 10.3390/polym14050936.
2
Ultrasound-Triggered Liposomes Encapsulating Quantum Dots as Safe Fluorescent Markers for Colorectal Cancer.超声触发的包裹量子点的脂质体作为结直肠癌的安全荧光标记物
Pharmaceutics. 2021 Dec 3;13(12):2073. doi: 10.3390/pharmaceutics13122073.
3
Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment.癌症治疗中的双靶点与刺激触发脂质体药物递送
Biomolecules. 2024 Dec 19;14(12):1628. doi: 10.3390/biom14121628.
4
Stimuli-Responsive Liposomes of 5-Fluorouracil: Progressive Steps for Safe and Effective Treatment of Colorectal Cancer.5-氟尿嘧啶的刺激响应性脂质体:安全有效治疗结直肠癌的进展
Pharmaceutics. 2024 Jul 22;16(7):966. doi: 10.3390/pharmaceutics16070966.
ACS Pharmacol Transl Sci. 2021 Jun 1;4(3):1028-1049. doi: 10.1021/acsptsci.1c00066. eCollection 2021 Jun 11.
4
Ultrasound-Responsive Nanocarriers in Cancer Treatment: A Review.癌症治疗中的超声响应性纳米载体:综述
ACS Pharmacol Transl Sci. 2021 Mar 3;4(2):589-612. doi: 10.1021/acsptsci.0c00212. eCollection 2021 Apr 9.
5
Effect of Pegylation and Targeting Moieties on the Ultrasound-Mediated Drug Release from Liposomes.聚乙二醇化和靶向部分对脂质体超声介导的药物释放的影响。
ACS Biomater Sci Eng. 2020 Jan 13;6(1):48-57. doi: 10.1021/acsbiomaterials.8b01301. Epub 2019 Jul 3.
6
Ultrasound-Mediated Drug Delivery in Cancer Therapy: A Review.超声介导的癌症治疗药物递送:综述。
J Nanosci Nanotechnol. 2020 Dec 1;20(12):7211-7230. doi: 10.1166/jnn.2020.18877.
7
Opportunities and challenges in commercial pharmaceutical liposome applications.商业制药脂质体应用的机遇与挑战。
Adv Drug Deliv Rev. 2020;154-155:2-12. doi: 10.1016/j.addr.2020.07.016. Epub 2020 Jul 22.
8
Improving the Efficacy of Anticancer Drugs via Encapsulation and Acoustic Release.通过封装和声控释放提高抗癌药物的疗效。
Curr Top Med Chem. 2018;18(10):857-880. doi: 10.2174/1568026618666180608125344.
9
Advances in Tumor Targeted Liposomes.肿瘤靶向脂质体的进展
Curr Mol Med. 2018;18(1):44-57. doi: 10.2174/1566524018666180416101522.
10
Liposomal Drug Delivery Systems and Anticancer Drugs.脂质体药物递送系统与抗癌药物。
Molecules. 2018 Apr 14;23(4):907. doi: 10.3390/molecules23040907.